trending Market Intelligence /marketintelligence/en/news-insights/trending/nrbl7fzz9okihsvyuawqsg2 content esgSubNav
In This List

Spectrum Pharmaceuticals appoints board member

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Spectrum Pharmaceuticals appoints board member

Henderson, Nev.-based Spectrum Pharmaceuticals Inc. added William Ashton to its board of directors.

Ashton was previously vice president for U.S. sales at Amgen Inc. His appointment expands the company's board to nine members.

Spectrum develops drug products for blood diseases and cancer.